Importantly, pharmacological inhibition of cMet (PS5+INH) significantly reduced experimental autoimmune myocarditis incidence, mononuclear cell infiltrates, collagen deposition, and cMet+ T cell infiltration as well as the echocardiographic correlates of AMP. Here, MET is linked to autoimmune myocarditis.